The generic challenge Leave a Comment / By DrugPatentWatch / April 29, 2019 Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/ Make Better Decisions with DrugPatentWatch » Start Your Free Trial Today « Copyright © DrugPatentWatch. Originally published at Related Posts:Development of the generic drug industry in the US…Differences in rates of switchbacks after switching…Comparing Generic Drug Markets in Europe and the…Development of Generic Drug Products by…Formulary Best Practice: Cost Containment through…Affordability and availability of off-patent drugs…Educating Patients about Generic Drugs: Strategies…Are Generic Drugs Less Safe than their Branded Equivalents?Customer Success: API and CDMO Business DevelopmentFactors that influence the development of generic…How to Identify Branded Drugs with a Low Likelihood…Understanding the Lifecycle of Generic Drugs: From…Obtaining Generic Drug Approval in the United StatesPrescribing of Generic Drugs Goes Up When Sales…A Comparison of Generic Drug Prices in Seven…Finding Generic Drug Entry Opportunities in Emerging MarketsPharmaceutical Formulary Management: Anticipating…A Comprehensive Generic Drug Naming Resource:…Innovative Approaches to Generic Drug Development:…Using FDA Product Specific Guidances (PSGs) as a…The Impact of Generic Drugs on Healthcare CostsCustomer Success: Law Firm Business DevelopmentHow to Use Tentative Drug Approvals to Anticipate…Opportunities for Generic Drug Development